VISHEE(SH:688580) Shang Hai Zheng Quan Bao·2026-01-18 18:36Core Viewpoint - The announcement details a share reduction plan by a major shareholder of Nanjing Weisi Medical Technology Co., Ltd., which may impact the company's stock performance and investor sentiment [1][3]. Shareholder Holding Situation - As of the announcement date, Nanjing Weisi Medical Technology Co., Ltd. has a major shareholder, Nanjing Zhida Venture Capital Center (Limited Partnership), holding 6,758,338 shares, representing 7.06% of the total share capital [2]. Reduction Plan Details - The shareholder plans to reduce their holdings by up to 2,873,137 shares, which is a maximum of 3% of the total share capital. This includes a maximum of 957,712 shares (1% of total shares) through centralized bidding and 1,915,425 shares (2% of total shares) through block trading, to be executed within three months after 15 trading days from the announcement [3][4]. Shareholder Commitments - The major shareholder has made commitments regarding shareholding, including a lock-up period of 36 months from the IPO date, during which they will not transfer shares. If the stock price falls below the issue price for 20 consecutive trading days, the lock-up period will be extended by at least six months [6][8]. Compliance with Regulations - The reduction plan complies with the relevant regulations of the Shanghai Stock Exchange and the China Securities Regulatory Commission, ensuring that the shareholder will adhere to legal requirements regarding shareholding and disclosure [13].